StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.83−0.02 (-2.80%)

Close on Nov 18, 2026Market cap $36.76MP/E –Yield –

Elutia operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Elutia's operating income for the twelve months ending Jun 30, 2026 was -$26.07M. For fiscal 2025 it was -$26.91M. The highest annual figure on record is -$8.41M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.91M–
FY2024Dec 31, 2024-$30.71M–
FY2023Dec 31, 2023-$30.53M–
FY2022Dec 31, 2022-$35.19M–
FY2021Dec 31, 2021-$23.03M–
FY2020Dec 31, 2020-$13.60M–
FY2019Dec 31, 2019-$8.41M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.96M–
Q1 FY2026Mar 31, 2026-$6.35M–
Q4 FY2025Dec 31, 2025-$6.56M–
Q3 FY2025Sep 30, 2025-$5.21M–
Q2 FY2025Jun 30, 2025-$8.37M–
Q1 FY2025Mar 31, 2025-$6.78M–
Q4 FY2024Dec 31, 2024-$7.46M–
Q3 FY2024Sep 30, 2024-$9.18M–
Q2 FY2024Jun 30, 2024-$8.51M–
Q1 FY2024Mar 31, 2024-$8.48M–
Q4 FY2023Dec 31, 2023-$8.51M–
Q3 FY2023Sep 30, 2023-$7.37M–
Q2 FY2023Jun 30, 2023-$6.31M–
Q1 FY2023Mar 31, 2023-$8.34M–
Q2 FY2022Jun 30, 2022-$8.18M–
Q1 FY2022Mar 31, 2022-$6.92M–
Q4 FY2021Dec 31, 2021-$7.76M–
Q3 FY2021Sep 30, 2021-$6.98M–
Q2 FY2021Jun 30, 2021-$4.60M–
Q1 FY2021Mar 31, 2021-$3.70M–
Q4 FY2020Dec 31, 2020-$3.96M–
Q3 FY2020Sep 30, 2020-$2.69M–
Q2 FY2020Jun 30, 2020-$3.76M–
Q1 FY2020Mar 31, 2020-$3.18M–
Q4 FY2019Dec 31, 2019-$3.21M–
Q3 FY2019Sep 30, 2019-$1.85M–

More Elutia figures

See a number that looks wrong?